Avmacol®: Clinical Trials

4 trials of Avmacol®, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 enrolling by invitation. 2 Phase 2, 1 Early Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Early Phase 11Completed 1
Not applicable1Enrolling by invitation 1

Follow Avmacol®: new trials by email Literature Review of Avmacol® trials Research Report on Avmacol®

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Validation Digital Bio-markers During Sulforaphane Treatment.
Sulforaphane - Autism, Autism Spectrum Disorder
Not applicableEnrolling by invitationRutgers, The State University of New Jersey102022-07-072025-10-30
Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers
Sulforaphane, Placebo - Lung Cancer
Phase 2CompletedJian-Min Yuan, MD432018-01-252024-12-17
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
Avmacol® - HNSCC, Head and Neck Cancer
Early Phase 1CompletedUniversity of Arizona62017-04-242021-06-21
Sulforaphane to Reduce Symptoms of Schizophrenia
Sulforaphane Nutraceutical, Identical-appearing Placebo - Schizophrenia, Schizoaffective Disorder
Phase 2CompletedSheppard Pratt Health System642017-02-222021-07-27

Conditions studied

Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Carcinoma in Situ (1)  ·  Head and Neck Neoplasms (1)  ·  Hyperplasia (1)  ·  Lung Neoplasms (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Smoking Cessation (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Jian-Min Yuan, MD (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Sheppard Pratt Health System (1)  ·  University of Arizona (1)

Countries

United States (4)

Top investigators

Faith Dickerson, PhD, MPH (1)  ·  Jian-Min Yuan, MD, PhD (1)  ·  Julie E. Bauman, MD, MPH (1)

Results publications

PMID 40041932

NIH funding

P50CA097190 (1), R01CA213123 (1)